Northwest Cancer Specialists — Portland, Oregon

Northwest Cancer Specialists is a clinical research site located in Portland, Oregon, United States 97227.

Crixeo Health Trust Score: 82/100 (GOOD). This profile has not yet been claimed by the site owner.

Northwest Cancer Specialists has participated in 18 clinical trials with 6 currently active.

Therapeutic areas: Uterine Serous Carcinoma, Metastatic Breast Cancer, Chronic Myelogenous Leukemia - Chronic Phase.

Sponsors: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc, Byondis B.V., Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 82/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Northwest Cancer Specialists?

Northwest Cancer Specialists has a Crixeo Trust Score of 82/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Northwest Cancer Specialists conducted?

Northwest Cancer Specialists has 18 clinical trials on record, with 6 currently active. Their work covers Uterine Serous Carcinoma, Metastatic Breast Cancer, Chronic Myelogenous Leukemia - Chronic Phase.

Is Northwest Cancer Specialists accredited by Crixeo Health?

Yes — Northwest Cancer Specialists holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Northwest Cancer Specialists?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.